Matrix metalloproteinase 2 as a pharmacological target in heart failure

PR Gonçalves, LD Nascimento, RF Gerlach… - Pharmaceuticals, 2022 - mdpi.com
Heart failure (HF) is an acute or chronic clinical syndrome that results in a decrease in
cardiac output and an increase in intracardiac pressure at rest or upon exertion. The …

[HTML][HTML] Matrix metalloproteinases as possible biomarkers of obstructive sleep apnea severity–a systematic review

A Franczak, I Bil-Lula, G Sawicki, M Fenton… - Sleep Medicine …, 2019 - Elsevier
Obstructive sleep apnea is an underdiagnosed sleep-related breathing disorder affecting
millions of people. Recurrent episodes of apnea/hypopnea result in intermittent hypoxia …

Injectable and protease-degradable hydrogel for siRNA sequestration and triggered delivery to the heart

LL Wang, JJ Chung, EC Li, S Uman, P Atluri… - Journal of Controlled …, 2018 - Elsevier
Injectable hydrogels have significant therapeutic potential for treatment of myocardial
infarction (MI) through tissue bulking and local drug delivery, including the delivery of small …

Morroniside protects against cerebral ischemia/reperfusion injury by inhibiting neuron apoptosis and MMP2/9 expression

G Zeng, W Ding, Y Li, M Sun… - Experimental and …, 2018 - spandidos-publications.com
The aim of the present study was to investigate the effect of morroniside against matrix
metalloproteinase (MMP) 2/9 and focal cerebral ischemia/reperfusion (I/R) injury in rats. A …

FOXN4 affects myocardial ischemia-reperfusion injury through HIF-1α/MMP2-mediated ferroptosis of cardiomyocytes

J Wang, M Deng, J Yang, X Zhou, P Yang… - Cellular and Molecular …, 2023 - cellmolbiol.org
Myocardial ischemia-reperfusion injury (MIRI) is an important factor leading to myocardial
injury and necrosis, and can induce ischemic heart disease. Forkhead box protein N4 …

Effects of physical prehabilitation on the dynamics of the markers of endothelial function in patients undergoing elective coronary bypass surgery

Y Argunova, E Belik, O Gruzdeva, S Ivanov… - Journal of Personalized …, 2022 - mdpi.com
Our aim in this study was to evaluate the effect of physical training performed before CABG
on the perioperative dynamics of the serum levels of asymmetric dimethylarginine (ADMA) …

Multidrug prevention or therapy of ischemia-reperfusion injury of the heart—Mini-review

A Krzywonos-Zawadzka, A Franczak, G Sawicki… - Environmental …, 2017 - Elsevier
Restoration of blood flow to myocardium previously subjected to ischemia leads to
ischemia/reperfusion injury due to oxidative stress. An increased production of toxic …

[PDF][PDF] L-NAME improves doxycycline and ML-7 cardioprotection from oxidative stress

I Bil-Lula, A Krzywonos-Zawadzka… - Frontiers in …, 2018 - article.imrpress.com
1. ABSTRACT Matrix metalloproteinase-2(MMP-2) mediated degradation of myosin light
chain 1 (MLC1) and troponin I (TnI) contributes to myocardial ischemia/reperfusion (I/R) …

Subthreshold nitric oxide synthase inhibition improves synergistic effects of subthreshold MMP‐2/MLCK‐mediated cardiomyocyte protection from hypoxic injury

I Bil‐Lula, HB Lin, D Biały… - Journal of Cellular …, 2016 - Wiley Online Library
Injury of myocardium during ischaemia/reperfusion (I/R) is a complex and multifactorial
process involving uncontrolled protein phosphorylation, nitration/nitrosylation by increased …

Silencing RNA for MMPs may be utilized for cardioprotection

M Banaszkiewicz… - Cardiovascular …, 2022 - Wiley Online Library
Ischemia/reperfusion (I/R) injury is accompanied by an increase of matrix metalloproteinase
2 (MMP‐2) activity, which degrades heart contractile proteins. The aim of the study was to …